| Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up K Dahan, H Debiec, E Plaisier, M Cachanado, A Rousseau, L Wakselman, ... Journal of the American Society of Nephrology 28 (1), 348-358, 2017 | 381 | 2017 |
| Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature V Audard, F Larousserie, P Grimbert, M Abtahi, JJ Sotto, A Delmer, ... Kidney international 69 (12), 2251-2260, 2006 | 226 | 2006 |
| Acute renal infarction: a case series M Bourgault, P Grimbert, C Verret, J Pourrat, M Herody, JM Halimi, ... Clinical Journal of the American Society of Nephrology 8 (3), 392-398, 2013 | 221 | 2013 |
| Feasibility, reproducibility, risks and benefits of face transplantation: a prospective study of outcomes L Lantieri, M Hivelin, V Audard, MD Benjoar, JP Meningaud, F Bellivier, ... American Journal of Transplantation 11 (2), 367-378, 2011 | 220 | 2011 |
| Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty V Audard, M Matignon, F Hemery, R Snanoudj, P Desgranges, ... American Journal of Transplantation 6 (1), 95-99, 2006 | 200 | 2006 |
| Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease H Munyentwali, K Bouachi, V Audard, P Remy, P Lang, R Mojaat, ... Kidney international 83 (3), 511-516, 2013 | 168 | 2013 |
| Recent approaches to the pathogenesis of minimal‐change nephrotic syndrome P Grimbert, V Audard, P Remy, P Lang, D Sahali Nephrology Dialysis Transplantation 18 (2), 245-248, 2003 | 146 | 2003 |
| Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview V Audard, M Matignon, K Dahan, P Lang, P Grimbert Transplant International 21 (1), 11-17, 2008 | 145 | 2008 |
| Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients A Pardon, V Audard, S Caillard, B Moulin, D Desvaux, B Bentaarit, ... Nephrology Dialysis Transplantation 21 (4), 1053-1059, 2006 | 119 | 2006 |
| Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum V Audard, B Georges, P Vanhille, B Deroure, F Fakhouri, X Belenfant, ... Clinical Journal of the American Society of Nephrology 3 (5), 1339-1349, 2008 | 115 | 2008 |
| Daratumumab in sensitized kidney transplantation: potentials and limitations of experimental and clinical use J Kwun, M Matignon, M Manook, S Guendouz, V Audard, D Kheav, ... Journal of the American Society of Nephrology 30 (7), 1206-1219, 2019 | 104 | 2019 |
| Acute graft pyelonephritis: a potential cause of acute rejection in renal transplant V Audard, M Amor, D Desvaux, M Pastural, C Baron, R Philippe, A Pardon, ... Transplantation 80 (8), 1128-1130, 2005 | 102 | 2005 |
| Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy H Izzedine, M Mangier, V Ory, SY Zhang, K Sendeyo, K Bouachi, ... Kidney international 85 (2), 457-470, 2014 | 99 | 2014 |
| Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study F Joly, C Cohen, V Javaugue, S Bender, M Belmouaz, B Arnulf, ... Blood, The Journal of the American Society of Hematology 133 (6), 576-587, 2019 | 98 | 2019 |
| Glomerular lesions in patients with sickle cell disease G Maigne, S Ferlicot, F Galacteros, X Belenfant, T Ulinski, P Niaudet, ... Medicine 89 (1), 18-27, 2010 | 93 | 2010 |
| Retrospective follow-up of transplantation of kidneys from ‘marginal’donors D Dahmane, V Audard, C Hiesse, F Pessione, B Bentaarit, B Barrou, ... Kidney international 69 (3), 546-552, 2006 | 92 | 2006 |
| Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease P Bartolucci, A Habibi, T Stehlé, G Di Liberto, MG Rakotoson, ... Journal of the American Society of Nephrology 27 (6), 1847-1853, 2016 | 90 | 2016 |
| Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization P Grimbert, A Valanciute, V Audard, A Pawlak, S Le gouvelo, P Lang, ... The Journal of experimental medicine 198 (5), 797-807, 2003 | 90 | 2003 |
| B7–1 blockade does not improve post–transplant nephrotic syndrome caused by recurrent FSGS M Delville, E Baye, A Durrbach, V Audard, T Kofman, L Braun, J Olagne, ... Journal of the American Society of Nephrology 27 (8), 2520-2527, 2016 | 88 | 2016 |
| C-mip impairs podocyte proximal signaling and induces heavy proteinuria SY Zhang, M Kamal, K Dahan, A Pawlak, V Ory, D Desvaux, V Audard, ... Science Signaling 3 (122), ra39-ra39, 2010 | 83 | 2010 |
